Oberkochen, Germany | ZEISS Group The ZEISS Ventures Portfolio startup Senorics GmbH, a high-tech spin-off from the University of Technology Dresden (TU Dresden) successfully closed a new financing round. Senorics is specialized in designing and manufacturing optical spectroscopic sensor solutions for mass market applications to make material sensing easy and affordable. Responding to the process […]

A Turnkey Solution for Molecular Structure Determination for Nanocrystals Rigaku Corporation (Headquarters: Akishima, Tokyo, Japan; Chairman & CEO: Hikaru Shimura), a leading company producing X-ray analysis instruments, and JEOL Ltd. (Headquarters: Akishima, Tokyo, Japan; President & COO: Izumi Oi), a leading company producing electron microscopes and other analytical instruments, have announced the launch of the […]

• Creating a fully automated robotic system will bring industrial scale reliability to cell therapy manufacturing while providing speed and flexibility • Automation readily used in other industries is now being tested in the cell therapy workflow • Technology has the potential to transform global healthcare as more cell therapies receive regulatory approval around the […]

Microba’s gut microbiome analysis platform and Illumina’s Next Generation Sequencing tools Powering studies from Parkinson’s disease to FMT Partnership aims to increase uptake of high-quality microbiome research and new discoveries Leaders in precision gut microbiome science Microba Life Sciences has united with Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies […]

Cellenion and ECOBIO laboratory (UMR CNRS-University of Rennes) have received a Labcom-2020 €360k grant by the French National Research Agency (ANR) for the creation of the joint MICROSCALE-Lab (MICRObial Single Cell AnaLysEs Laboratory). The overall objective of this 5-year project is to offer a complete solution for the isolation, library preparation and bioinformatic analysis of […]

FLAMIN-GO Project Seeks to Develop Organ-on-a-Chip Technology for Clinical Trials in Rheumatoid Arthritis Therapy SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it has joined the FLAMIN-GO Project consortium of academic and industry leaders in rheumatology, autoimmune disease […]

Australian National Phenome Centre Integrates Quantitative NMR and MS Assay Platform for Risk Assessment and Longitudinal Monitoring of Post-Acute COVID-19 Syndrome (PACS) PERTH, Australia — A clinical research collaboration on COVID-19 pheno-conversion and subsequent pheno-reversion has discovered transient and persistent systemic changes of the molecular signatures in patient blood samples three months after the acute COVID-19 […]

Industry-leading 3D ligand-based design approaches from BioPharmics will be available in StarDrop, Optibrium’s small molecule design and optimisation software. CAMBRIDGE, UK: Optibrium Ltd and BioPharmics LLC, leading providers of software and computational solutions for drug discovery, today announce their partnership. The collaboration will combine industry-leading computational design solutions with advanced interactive user interfaces, engaging with experimental […]

InSphero and Hamilton Announce Collaboration to Improve the Production and Handling of Spheroids Using Advanced Liquid Handling Technology Both partners have a proven track record for being a successful entrepreneur and a technical disruptor at the intersection of 3D in vitro technologies and automation.  Schlieren, Switzerland – InSphero AG, the pioneer of 3D cell-based assay technology […]

New facility will provide end-to-end solution to accelerate cell therapy development and manufacturing WALTHAM, Mass. and SAN FRANCISCO — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and the University of California, San Francisco (UCSF) today announced they have formed a strategic alliance to accelerate the development and manufacturing of cell-based therapies. […]